Bullish (BLSH) operates Bullish Exchange, a digital-asset spot and derivatives venue, along with the CoinDesk family of indices, market data, and media properties. After trading in a wide 52-week range from roughly $20 to $75, shares have settled in the low $40s. Several Wall Street firms, including Bernstein and Citi, have set price targets at exactly $50, which naturally raises the question of whether BLSH can get there.
BLSH recently closed near $40.70, with a market capitalization of roughly $6 billion. The company has posted net losses over the trailing twelve months, yet sell-side estimates point to a return to positive EPS this fiscal year and revenue growth of about 50%. That shift from losses to profitability is a key factor in assessing whether a move toward $50 makes sense.
Two main elements underpin the case for $50: ongoing fundamental growth and the tokenization narrative. Bullish earns revenue from trading, indices, data, and media, creating multiple avenues tied to digital-asset activity. Analysts project meaningful revenue expansion this year and next, which could support a higher valuation with solid execution.
The tokenization angle adds another layer. Bullish has agreed to acquire Equiniti, a transfer agent with connections to thousands of issuers and millions of verified shareholders. Pairing that infrastructure with blockchain technology is seen as a route into tokenizing traditional securities. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Bernstein has positioned Bullish within the real-world asset trend, noting that broader U.S. crypto adoption has continued despite some regulatory hurdles.
Wall Street sentiment is generally positive. The consensus rating is Buy or Hold depending on the source, with a consensus twelve-month target in the low-to-mid $40s and a high estimate above $60. Recent updates include Compass Point raising its rating to Buy with a $51 target, Clear Street lifting its target to $43, and both Citi and Bernstein holding $50 objectives. A few firms maintain lower targets near $25 to $30, showing real differences of opinion on how quickly the businesses can scale. This range of views makes $50 plausible for optimists but far from certain.
Technically, the stock sits well below its 52-week high, so $50 represents both a psychological milestone and a potential area of supply. Support appears in the upper $30s to low $40s, with a deeper level around the mid-$30s. A sustained move above the mid-$40s would be a meaningful step, indicating buyers are absorbing overhead supply ahead of any push toward $50.
Several factors could slow progress. Bullish remains closely linked to digital-asset markets, which are subject to sharp swings driven by sentiment. A sustained drop in crypto volumes or prices could weigh on trading revenue and delay the expected return to profitability. Regulatory changes present both opportunity and risk, while the current valuation already prices in significant growth, leaving little margin if revenue or the Equiniti integration falls short.
When evaluating stocks like BLSH, I often turn to Tickeron’s AI Daily Buy/Sell Signals to monitor momentum shifts. This tool applies artificial intelligence across thousands of stocks and ETFs to generate Buy, Sell, or Hold signals based on market conditions and technical factors. It helps me track developments efficiently without replacing my own analysis.
The route to $50 for Bullish appears realistic under favorable conditions but is not assured. Support comes from expected double-digit revenue growth, the move toward profitability, and a strategic role in tokenization, backed by multiple $50 analyst targets. Key risks include crypto volatility, regulatory shifts, and execution on the Equiniti deal. Watching revenue trends, exchange volumes, progress on positive EPS, and any tokenization or regulatory news will be important. Reaching $50 will likely depend on sustained fundamental improvement.
In my own workflow, Tickeron’s AI Daily Buy/Sell Signals has become a useful addition for tracking momentum on names like BLSH. The platform scans thousands of securities in real time and surfaces signals that help me stay on top of changing conditions without adding extra screen time.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
BLSH saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 16, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 9 instances where the indicator turned negative. In 9 of the 9 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BLSH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for BLSH entered a downward trend on November 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BLSH's RSI Indicator exited the oversold zone, 7 of 8 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +10.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where BLSH advanced for three days, in 44 of 55 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
BLSH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.338) is normal, around the industry mean (16.188). P/E Ratio (-2.131) is within average values for comparable stocks, (45.064). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.427) among similar stocks. P/S Ratio (0.026) is also within normal values, averaging (103.301).
The Tickeron PE Growth Rating for this company is 40 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. BLSH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BLSH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ComputerCommunications